213 related articles for article (PubMed ID: 11567755)
1. Seroprevalence of varicella-zoster virus in the German population.
Wutzler P; Färber I; Wagenpfeil S; Bisanz H; Tischer A
Vaccine; 2001 Oct; 20(1-2):121-4. PubMed ID: 11567755
[TBL] [Abstract][Full Text] [Related]
2. Varicella-zoster virus seroprevalence in children and adolescents in the pre-varicella vaccine era, Germany.
Wiese-Posselt M; Siedler A; Mankertz A; Sauerbrei A; Hengel H; Wichmann O; Poethko-Müller C
BMC Infect Dis; 2017 May; 17(1):356. PubMed ID: 28525973
[TBL] [Abstract][Full Text] [Related]
3. Seroepidemiology of varicella-zoster virus infection in a cosmopolitan city (Erzurum) in the eastern Turkey.
Alp H; Altinkaynak S; Ertekin V; Kiliçaslan B; Giiraksin A
Health Policy; 2005 Apr; 72(1):119-24. PubMed ID: 15760704
[TBL] [Abstract][Full Text] [Related]
4. Varicella zoster virus infection occurs at a relatively young age in The Netherlands.
van Lier A; Smits G; Mollema L; Waaijenborg S; Berbers G; van der Klis F; Boot H; Wallinga J; de Melker H
Vaccine; 2013 Oct; 31(44):5127-33. PubMed ID: 23973248
[TBL] [Abstract][Full Text] [Related]
5. [Varicella-zoster virus seroprevalence in children between 0-15 years old].
Savaş S; Dallar Y; Arikan I; Onde U
Mikrobiyol Bul; 2004; 38(1-2):69-75. PubMed ID: 15293904
[TBL] [Abstract][Full Text] [Related]
6. Seroprevalence of varicella-zoster virus in Polish population.
Siennicka J; Trzcińska A; Rosińska M; Litwińska B
Przegl Epidemiol; 2009; 63(4):495-9. PubMed ID: 20120946
[TBL] [Abstract][Full Text] [Related]
7. Nosocomial transmission of chickenpox and varicella zoster virus seroprevalence rate amongst healthcare workers in a teaching hospital in China.
Yang J; Liu J; Xing F; Ye H; Dai G; Liu M; Lo SK; Lau RW; Chiu KH; Chan JF; Yuen KY
BMC Infect Dis; 2019 Jul; 19(1):582. PubMed ID: 31277589
[TBL] [Abstract][Full Text] [Related]
8. Changes in age related seroprevalence of antibody to varicella zoster virus: impact on vaccine strategy.
Kudesia G; Partridge S; Farrington CP; Soltanpoor N
J Clin Pathol; 2002 Feb; 55(2):154-5. PubMed ID: 11865016
[TBL] [Abstract][Full Text] [Related]
9. Varicella seroprevalence in Turkish population in Cyprus.
Kurugol Z; Koturoglu G; Aksit S; Ozacar T
Acta Paediatr; 2007 Jun; 96(6):861-3. PubMed ID: 17465984
[TBL] [Abstract][Full Text] [Related]
10. Seroprevalence of varicella-zoster virus in Korea.
Choi WS; Noh JY; Huh JY; Jo YM; Lee J; Song JY; Kim WJ; Cheong HJ
J Med Virol; 2010 Dec; 82(12):2123-6. PubMed ID: 20981803
[TBL] [Abstract][Full Text] [Related]
11. A seroepidemiologic survey of the prevalence of varicella-zoster virus in the pediatric population in two university hospitals in Brazil.
Semenovitch I; Lupi O
Int J Dermatol; 2003 Mar; 42(3):193-6. PubMed ID: 12653913
[TBL] [Abstract][Full Text] [Related]
12. Seroprevalence of varicella-zoster virus and predictors for seronegativity in the Amsterdam adult population.
van Rijckevorsel GG; Damen M; Sonder GJ; van der Loeff MF; van den Hoek A
BMC Infect Dis; 2012 Jun; 12():140. PubMed ID: 22721551
[TBL] [Abstract][Full Text] [Related]
13. Varicella zoster virus in American Samoa: seroprevalence and predictive value of varicella disease history in elementary and college students.
Mahamud A; Leung J; Masunu-Faleafaga Y; Teshale E; Williams R; Dulski T; Thieme M; Garcia P; Schmid DS; Bialek SR
Epidemiol Infect; 2014 May; 142(5):1002-7. PubMed ID: 23890292
[TBL] [Abstract][Full Text] [Related]
14. Varicella seroepidemiology in United States air force recruits: A retrospective cohort study comparing immunogenicity of varicella vaccination and natural infection.
Duncan JR; Witkop CT; Webber BJ; Costello AA
Vaccine; 2017 Apr; 35(18):2351-2357. PubMed ID: 28359621
[TBL] [Abstract][Full Text] [Related]
15. Seroprevalence of Varicella-Zoster virus IgG antibodies in Swiss children during the first 16 months of age.
Heininger U; Desgrandchamps D; Schaad UB
Vaccine; 2006 Apr; 24(16):3258-60. PubMed ID: 16459000
[TBL] [Abstract][Full Text] [Related]
16. Susceptibility to varicella in childbearing age women, Central Italy: is there a need for vaccinating this population group?
Alfonsi V; Montomoli E; Manini I; Alberini I; Gentile C; Rota MC; Ciofi degli Atti ML
Vaccine; 2007 Aug; 25(32):6086-8. PubMed ID: 17629374
[TBL] [Abstract][Full Text] [Related]
17. Seroprevalence of varicella-zoster virus among pregnant women in Fayoum Governorate, Egypt.
Ibrahim EG; Abdel Wahed WY; Eid HM; Deeb WS
J Egypt Public Health Assoc; 2019; 94(1):2. PubMed ID: 30686830
[TBL] [Abstract][Full Text] [Related]
18. Immunity to varicella zoster virus among young adults: a decline prior to widespread uptake of varicella vaccines.
Grotto I; Balicer RD; Smetana Z; Davidovitch N; Bar-Zeev Y; Mendelson E; Zarka S; Huerta M
Infection; 2008 Mar; 36(2):130-4. PubMed ID: 18379727
[TBL] [Abstract][Full Text] [Related]
19. Age-specific seroprevalence to varicella-zoster virus: study in Swiss children and analysis of European data.
Aebi C; Fischer K; Gorgievski M; Matter L; Mühlemann K
Vaccine; 2001 Apr; 19(23-24):3097-103. PubMed ID: 11312004
[TBL] [Abstract][Full Text] [Related]
20. Seroprevalences of varicella-zoster virus, herpes simplex virus and cytomegalovirus in a cross-sectional study in Mexico.
Conde-Glez C; Lazcano-Ponce E; Rojas R; DeAntonio R; Romano-Mazzotti L; Cervantes Y; Ortega-Barria E
Vaccine; 2013 Oct; 31(44):5067-74. PubMed ID: 24021305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]